“…Bauerova and Bezek (1999) and Jaswal et al (2003) described oxidative stress as a primary factor involved in the RA pathogenetic changes. Our previous results with different antioxidants and immunomodulators showed a beneficial effect of these substances on the development of adjuvant arthritis (AA) (Bauerova et al , 2005a, 2005b
2008a, 2008b
2009, 2011, Drabikova et al , 2009; Drafi et al , 2010; Jancinova et al , 2009; Kogan et al , 2005; Macickova et al , 2010; Ponist et al , 2010; Sotnikova et al , 2009; Strosova et al , 2008, 2009). The advantage of AA as an experimental arthritis model is its great similarity to RA, such as symmetrical joint involvement, persistent joint inflammation, synovial hyperplasia, and a good response to most therapies effective in RA (Bina & Wilder, 1999).…”